• Davidi Vortman

    Davidi Vortman is the CEO of UltraSight. With over 20 years of experience as a tech entrepreneur, Davidi has founded and grown several public and private high technology companies such as Lumos Global, Comverse Technologies, and NICE Systems (NASDAQ: NICE), and has a proven track record for managing ventures with consistent revenue growth. He holds […]

  • Itay Kezurer

    Itay Kezurer is Co-Founder and Chief Technology Officer of UltraSight. Itay brings algorithm development in the field of computer vision and computer graphics knowledge to the team. Prior to UltraSight, Itay was an algorithmic engineer at Elbit Systems. Itay holds an MSc in Applied Mathematics and Computer Science from the Weizmann Institute of Science, and […]

  • Achi Ludomirsky, MD

    Achi Ludomirsky is Co-Founder and Chief Medical Officer at UltraSight. Achi is also a professor of pediatric cardiology and pediatrics and is the associate chair of Pediatric Outreach at NYU School of Medicine. Dr. Ludomirsky is a pioneer in fetal and pediatric heart imaging and is internationally known for his instrumental role in the development […]

  • Yaron Lipman, PhD

    Yaron Lipman is Co-Founder and Chief Scientific Officer of UltraSight. Yaron is also an associate professor at the Department of Computer Science and Applied Mathematics at the Weizmann Institute of Science, Israel. Yaron’s research focuses on geometric modeling and processing, shape comparison and analysis, and geometric deep learning. Yaron holds a PhD from Tel Aviv […]

  • Xen Mendelsohn Aderka

    Xen Mendelsohn Aderka is Vice President of Marketing at UltraSight. Xen is a marketing professional with 17 years of experience in medical technology and high technology. Previously, Xen was INSIGHTEC’s VP of Marketing where she built a global marketing organization and provided the leadership, strategy and execution for global marketing programs.  Xen holds a B.A. […]

  • Raanan Gonen

    Raanan Gonen is UltraSight’s Vice President of Research and Development. He is an experienced AI and machine learning architect and enterprise software professional. He has led the design of multiple AI-based products and research projects and has a proven ability to build architecture from A-Z to create a final production design. Raanan holds a BSc […]

  • Danny Spiegelstein, MD

    Danny Spiegelstein MD is UltraSight’s Vice President of Medical. Dr. Spiegelstein has 20+ years of medical experience in cardiovascular invasive medicine. He is an experienced clinical research investigator, managing protocols and operations in compliance with GMP and other regulatory requirements. Prior to UltraSight, Dr. Spiegelstein served as a consultant for medical start-ups in cardiology.

  • Noa Avisar, PhD

    Noa Avisar is UltraSight’s Vice President of Clinical Affairs and has 20 years of experience in drug and device development. She led the clinical development of oncology and neurology projects at Teva Pharmaceuticals and was the project development leader for various drugs from oncology to autoimmunology. Dr. Avisar has published 13 papers in scientific journals. […]

  • Sarah Mowery, MPAS, PA-C

    Sarah Mowery is the Vice President of Operations at UltraSight. A board-certified clinician, with over 15 years in healthcare, Sarah brings a proven track record of building innovative and disruptive healthcare services at scale, enhancing patient and provider experience, improving accessibility to high quality healthcare, and driving organizational financial performance. Prior to UltraSight, Sarah held […]

  • Andrew Goldsmith, MD, MBA 

    Dr. Andrew Goldsmith is the Medical Director at UltraSight. He is currently the Division Chief of Emergency Ultrasound at Brigham and Women’s Hospital and an Instructor at Harvard Medical School. Dr. Goldsmith is an avid researcher with over 50 peer-reviewed publications. He is currently an NIH principal investigator on AI POCUS research in clinical pathways in heart failure. Further, Dr. Goldsmith was a […]